|
Jacqueline M. Wilentz Comprehensive Breast Center actively pursues
research opportunities to provide patients with additional treatment
choices.
RTOG 1014 A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation (PBRI) for Local Recurrence of Breast Carcinoma
NSABP B-47 A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node Negative Her2-Low Invasive Breast Cancer
RTOG 1005
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost Versus Standard Whole Breast Irradiation plus Sequential Boost for Early – Stage Breast Cancer
NSABP DMP-1
A Study to Evaluate Different Decision Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer
[ top ] |